Taken together, the clinical analyses of SPOCK1 indicate that SPOCK1 may play a critical role in ccRCC progression and could serve as a biomarker for early detection and precise prognoses. The gene discussed is SPOCK1; the disease is nonpapillary renal cell carcinoma.